Jami Rubin
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Jami Rubin
Earlier roles on record: Board Member at Relay Therapeutics, Inc. (RLAY) until June 8, 2025. Relay Therapeutics, Inc. reported in an 8-K filed June 11, 2025 that Jami Rubin resigned as Class III Director, effective June 8, 2025.
“On June 8, 2025, Jami Ruben informed the Board of Directors (the "Board") of Relay Therapeutics, Inc. (the "Company") that she is resigning as a member of the Board and as a member of Audit Committee of the Board (the "Audit Committee"), effective immediately.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2025-06-08
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.